These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15234670)

  • 61. Commensal oral bacteria antigens prime human dendritic cells to induce Th1, Th2 or Treg differentiation.
    Kopitar AN; Ihan Hren N; Ihan A
    Oral Microbiol Immunol; 2006 Feb; 21(1):1-5. PubMed ID: 16390334
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis.
    Li X; Xiao BG; Xi JY; Lu CZ; Lu JH
    Clin Immunol; 2008 Feb; 126(2):180-8. PubMed ID: 18054287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma.
    Dmoszynska A; Podhorecka M; Manko J; Bojarska-Junak A; Rolinski J; Skomra D
    Neoplasma; 2005; 52(2):175-81. PubMed ID: 15800717
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between the clinico radiological heterogeneity and the immune-inflammatory profiles in pediatric patients with neurocysticercosis from a tertiary referral centre.
    Kashyap B; Das S; Jain S; Agarwal A; Kaushik JS; Kaur IR
    J Trop Pediatr; 2012 Aug; 58(4):320-3. PubMed ID: 22123942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TH2 profile in asymptomatic Taenia solium human neurocysticercosis.
    Chavarría A; Roger B; Fragoso G; Tapia G; Fleury A; Dumas M; Dessein A; Larralde C; Sciutto E
    Microbes Infect; 2003 Oct; 5(12):1109-15. PubMed ID: 14554252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Taenia antigens detection in the cerebrospinal fluid of patients with neurocysticercosis and its relationship with clinical activity of the disease.
    Abraham R; Pardini AX; Vaz AJ; Livramento JA; Machado Ldos R
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):756-60. PubMed ID: 15476063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Humoral and cellular immune response within the subarachnoid space of patients with neurocysticercosis.
    Ostrosky-Zeichner L; García-Mendoza E; Ríos C; Sotelo J
    Arch Med Res; 1996; 27(4):513-7. PubMed ID: 8987187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The cerebrospinal fluid and neurocysticercosis: evolutional aspects of the cellular inflammatory response].
    Machado LR
    Arq Neuropsiquiatr; 1987 Dec; 45(4):353-63. PubMed ID: 3449020
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of the cerebrospinal fluid laboratory parameters in the ELISA test for neurocysticercosis using a total cysticerci antigen.
    Casanova CS; Ribeiro MJ; Gonçalves RR; Faria LC; Peralta JM; Puccioni-Sohler M
    Arq Neuropsiquiatr; 2006 Mar; 64(1):55-9. PubMed ID: 16622554
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis.
    Rodrigues V; de-Mello FA; Magalhães EP; Ribeiro SB; Marquez JO
    Braz J Med Biol Res; 2000 Sep; 33(9):1059-63. PubMed ID: 10973138
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cellular immune response in intraventricular experimental neurocysticercosis.
    Moura VB; Lima SB; Matos-Silva H; Vinaud MC; Loyola PR; Lino RS
    Parasitology; 2016 Mar; 143(3):334-42. PubMed ID: 26626017
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of Taenia solium neurocysticercosis upon endocrine status and its relation with immuno-inflammatory parameters.
    Cárdenas G; Valdez R; Sáenz B; Bottasso O; Fragoso G; Sciutto E; Romano MC; Fleury A
    Int J Parasitol; 2012 Feb; 42(2):171-6. PubMed ID: 22233829
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis.
    Chavarria A; Fleury A; Bobes RJ; Morales J; Fragoso G; Sciutto E
    Microbes Infect; 2006 Apr; 8(4):1082-9. PubMed ID: 16520076
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cellular immune responses in human neurocysticercosis.
    Grewal JS; Kaur S; Bhatti G; Sawhney IM; Ganguly NK; Mahajan RC; Malla N
    Parasitol Res; 2000 Jun; 86(6):500-3. PubMed ID: 10894478
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors.
    Fleury A; Escobar A; Fragoso G; Sciutto E; Larralde C
    Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):243-50. PubMed ID: 20116079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cysticerci drive dendritic cells to promote in vitro and in vivo Tregs differentiation.
    Adalid-Peralta L; Arce-Sillas A; Fragoso G; Cárdenas G; Rosetti M; Casanova-Hernández D; Rangel-Escareño C; Uribe-Figueroa L; Fleury A; Sciutto E
    Clin Dev Immunol; 2013; 2013():981468. PubMed ID: 23762101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment-Resistant Human Extraparenchymal Neurocysticercosis: An Immune-Inflammatory Approach to Cysticidal Treatment Outcome.
    Arce-Sillas A; Cárdenas G; Álvarez-Luquín D; Hernandez M; Del Rey A; Besedovsky H; Gómez-Fuentes S; Fragoso G; Fleury A; Sciutto E; Adalid-Peralta L
    Neuroimmunomodulation; 2018; 25(2):103-109. PubMed ID: 30041237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.